METHODS This observational study includes all IBD patients (children and adults) regularly followed in our tertiary referral centre at “Papa Giovannni XXIII Hospital”, Bergamo, Italy from February 19th to March 23rd 2020. As per our follow up policy, patients can communicate with our team through a dedicated email or a phone number reaching a case manager; thus any complication, including signs of SARS-CoV-2 infection, are promptly notified to our team. Moreover, all patients admitted to the hospital undergo a nasopharyngeal swab to identify carriers of SARS-CoV-2.